Literature DB >> 1736892

Insertion of isolated insulin receptors into placental membrane vesicles.

K Christiansen1, J Carlsen.   

Abstract

Purified human insulin receptors were inserted into placental plasma-membrane vesicles by fusion of membranes with receptor-lysophosphatidylcholine micelles. Scatchard analysis of insulin binding showed that about 10-15% of the added receptors became inserted into the membrane. The receptor number could be increased about 3-fold, corresponding to approx. 5 pmol of receptor/mg of membrane protein. The receptors became firmly bound to the membrane, as they could not be removed by extensive wash. The insertion of exogenous receptors could be demonstrated by immunoblotting. The inserted insulin receptor had the same insulin-binding affinity as the isolated receptor and the endogenous receptor of the membrane. Insulin binding in the presence or absence of Triton X-100 revealed that more than 80% of the exogenous receptors had a right-side-out orientation. Function of the inserted receptors, as observed by insulin-stimulated autophosphorylation, could be demonstrated. About 80% of the added lysophospholipid, corresponding to approx. 160 nmol of lysophospholipid/mg of membrane protein, became integrated into the membrane and was partly metabolized to phospholipid and to non-esterified fatty acid. The method of insertion of isolated insulin receptors using the natural detergent, lysophospholipid, may be a method for insertion of receptors into intact cells, where the lysophospholipid, as in the plasma-membrane vesicles, will be acylated to phospholipid.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736892      PMCID: PMC1130702          DOI: 10.1042/bj2810425

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase.

Authors:  P L Rothenberg; W S Lane; A Karasik; J Backer; M White; C R Kahn
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Transfer of functional insulin receptors to receptor-deficient target cells.

Authors:  C Hofmann; R Thys; L J Sweet; A A Spector; J E Pessin
Journal:  Endocrinology       Date:  1988-06       Impact factor: 4.736

4.  The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.

Authors:  Y Ebina; L Ellis; K Jarnagin; M Edery; L Graf; E Clauser; J H Ou; F Masiarz; Y W Kan; I D Goldfine
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

5.  Quantitative electrophoretic transfer of polypeptides from SDS polyacrylamide gels to nitrocellulose sheets: a method for their re-use in immunoautoradiographic detection of antigens.

Authors:  P F Erickson; L N Minier; R S Lasher
Journal:  J Immunol Methods       Date:  1982-06-11       Impact factor: 2.303

6.  Immunization, isolation of immunoglobulins, estimation of antibody titre.

Authors:  N Harboe; A Ingild
Journal:  Scand J Immunol Suppl       Date:  1973

Review 7.  The nature and regulation of the insulin receptor: structure and function.

Authors:  M P Czech
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

8.  A model for the quaternary structure of human placental insulin receptor deduced from electron microscopy.

Authors:  K Christiansen; J Tranum-Jensen; J Carlsen; J Vinten
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

9.  Reconstitution of a protein into lipid vesicles using natural detergents.

Authors:  K Christiansen; J Carlsen
Journal:  Biochim Biophys Acta       Date:  1983-11-09

10.  High de novo synthesis of glycerolipids compared to deacylation-reacylation in rat liver microsomes.

Authors:  P L Fox; D B Zilversmit
Journal:  Biochim Biophys Acta       Date:  1982-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.